Evaluation and Modeling of the G-CSF Effect on the Evolution of Neutrophils During Chemotherapy Based on Eribulin
Phase of Trial: Phase IV
Latest Information Update: 24 Jun 2017
At a glance
- Drugs Eribulin (Primary)
- Indications Advanced breast cancer
- Focus Pharmacodynamics
- Acronyms EMEG-E-01
- 19 Jun 2017 Planned End Date changed from 1 Jul 2017 to 3 Dec 2018.
- 19 Jun 2017 Planned primary completion date changed from 1 May 2017 to 3 Jun 2018.
- 10 Jun 2017 Biomarkers information updated